
    
      Primary objective is to evaluate the efficacy of single-dose treatment with GSK1358820
      compared with non-treatment in patients with strabismus based on angles of strabismus in the
      primary position. Secondary objective is to evaluate the efficacy and safety of repeated-dose
      treatment with GSK1358820 in patients with strabismus.
    
  